Cyanosis resident survival guide: Difference between revisions
(45 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{| class="infobox" style="margin: 0 0 0 0; border: 0; float: right; width: 100px; background: #A8A8A8; position: fixed; top: 250px; right: 21px; border-radius: 0 0 10px 10px;" cellpadding="0" cellspacing="0" ; | |||
|- | |||
! style="padding: 0 5px; font-size: 85%; background: #A8A8A8" align="center" |{{fontcolor|#2B3B44|Cyanosis Resident Survival Guide Microchapters}} | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Cyanosis resident survival guide#Overview|Overview]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Cyanosis resident survival guide#Causes|Causes]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Cyanosis resident survival guide#Diagnosis|Diagnosis]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Cyanosis resident survival guide#Differential Diagnosis of Peripheral and Central Cyanosis|Differential Diagnosis]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Cyanosis resident survival guide#Treatment|Treatment]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Cyanosis resident survival guide#Do's|Do's]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Cyanosis resident survival guide#Don'ts|Don'ts]] | |||
|} | |||
{{WikiDoc CMG}}; {{AE}} {{Sara.Zand}} {{CK}} | |||
{{ | {{SK}} Cyanosis approach, Cyanosis workup, Cyanosis management, Approach to blue discoloration of skin, Hypoxemia approach, Hypoxia approach | ||
==Overview== | ==Overview== | ||
Cyanosis is defined as bluish discoloration of [[skin]] and [[mucous membrane]] due to decreased [[oxygenation]] of tissue. 2% of oxygen | [[Cyanosis]] is defined as bluish discoloration of [[skin]] and [[mucous membrane]] due to decreased [[oxygenation]] of tissue. Approximately 2% of oxygen dissolved in [[plasma]] and 98% is carried by [[hemoglobin]]. In [[central cyanosis]], there is decreased [[oxygen saturation]] (less than 85%) or abnormal or nonfunctional [[hemoglobin]], depending on whether reduced [[hemoglobin]] or desaturated hemoglobin exceeds 5 g/dl. Common signs of [[central cyanosis]] include the [[tongue]] and [[conjunctiva]] appearing blue in color and the extremities becoming warm with rapid [[capillary filling]]. In [[peripheral cyanosis]], the [[oxygen saturation]] is normal but there is inadequate delivery of [[oxygen]] to tissue or increased [[oxygen]] extraction by tissue due to peripheral [[vasoconstriction]]. In [[peripheral cyanosis]] extremities are [[cyanotic]], [[pale]], [[cool]] but [[tongue]] and [[conjunctiva]] are [[pinkish]]. All causes of [[central cyanosis]] may lead to [[peripheral cyanosis]]. In the presence of [[anemia]] and severe [[hypoxemia]], [[cyanosis]] may not be apparent due to fewer levels of reduced [[hemoglobin]]. Conversely, in [[polycythemia]] and mild [[hypoxemia]], [[cyanosis]] may be easily apparent due to an increased level of reduced [[hemoglobin]]. | ||
==Causes== | ==Causes== | ||
===Life Threatening Causes=== | ===Life Threatening Causes=== | ||
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated. | Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated. | ||
*[[Carbon monoxide poisoning]] <ref name="pmid19445736">{{cite journal |vauthors=Olson K, Smollin C |title=Carbon monoxide poisoning (acute) |journal=BMJ Clin Evid |volume=2008 |issue= |pages= |date=July 2008 |pmid=19445736 |pmc=2907971 |doi= |url=}}</ref> | *[[Carbon monoxide poisoning]] <ref name="pmid19445736">{{cite journal |vauthors=Olson K, Smollin C |title=Carbon monoxide poisoning (acute) |journal=BMJ Clin Evid |volume=2008 |issue= |pages= |date=July 2008 |pmid=19445736 |pmc=2907971 |doi= |url=}}</ref> | ||
*[[Cyanide poisoning]] <ref name="pmid29417853">{{cite journal |vauthors=Parker-Cote JL, Rizer J, Vakkalanka JP, Rege SV, Holstege CP |title=Challenges in the diagnosis of acute cyanide poisoning |journal=Clin Toxicol (Phila) |volume= |issue= |pages=1–9 |date=February 2018 |pmid=29417853 |doi=10.1080/15563650.2018.1435886 |url=}}</ref> | *[[Cyanide poisoning]] <ref name="pmid29417853">{{cite journal |vauthors=Parker-Cote JL, Rizer J, Vakkalanka JP, Rege SV, Holstege CP |title=Challenges in the diagnosis of acute cyanide poisoning |journal=Clin Toxicol (Phila) |volume= |issue= |pages=1–9 |date=February 2018 |pmid=29417853 |doi=10.1080/15563650.2018.1435886 |url=}}</ref> | ||
Line 35: | Line 50: | ||
*[[Birth asphyxia]] <ref name="pmid19727322">{{cite journal |vauthors=Steinhorn RH |title=Evaluation and management of the cyanotic neonate |journal=Clin Pediatr Emerg Med |volume=9 |issue=3 |pages=169–175 |date=September 2008 |pmid=19727322 |pmc=2598396 |doi=10.1016/j.cpem.2008.06.006 |url=}}</ref> | *[[Birth asphyxia]] <ref name="pmid19727322">{{cite journal |vauthors=Steinhorn RH |title=Evaluation and management of the cyanotic neonate |journal=Clin Pediatr Emerg Med |volume=9 |issue=3 |pages=169–175 |date=September 2008 |pmid=19727322 |pmc=2598396 |doi=10.1016/j.cpem.2008.06.006 |url=}}</ref> | ||
*[[Amniotic fluid embolism]]<ref name="pmid27275041">{{cite journal |vauthors=Kaur K, Bhardwaj M, Kumar P, Singhal S, Singh T, Hooda S |title=Amniotic fluid embolism |journal=J Anaesthesiol Clin Pharmacol |volume=32 |issue=2 |pages=153–9 |date= 2016 |pmid=27275041 |pmc=4874066 |doi=10.4103/0970-9185.173356 |url=}}</ref> | *[[Amniotic fluid embolism]]<ref name="pmid27275041">{{cite journal |vauthors=Kaur K, Bhardwaj M, Kumar P, Singhal S, Singh T, Hooda S |title=Amniotic fluid embolism |journal=J Anaesthesiol Clin Pharmacol |volume=32 |issue=2 |pages=153–9 |date= 2016 |pmid=27275041 |pmc=4874066 |doi=10.4103/0970-9185.173356 |url=}}</ref> | ||
===Common Causes=== | ===Common Causes=== | ||
{{familytree/start}} | {{familytree/start}} | ||
Line 175: | Line 191: | ||
==Diagnosis== | ==Diagnosis== | ||
<span style="font-size:85%">'''Abbreviations:''' | |||
'''TGA:''' [[Transposition of great arteries]]; | |||
'''COPD:''' [[Chronic obstructive pulmonary disease]]; | |||
'''PDA:''' Patent ductus arteriosus ; | |||
'''ASD:''' [[Atrial septal defect]]; | |||
'''VSD:''' [[Ventricular septal defect]]; | |||
'''TAPVR:''' [[Total anomalous pulmonary venous return]]; | |||
'''TOF:''' [[Tetralogy of fallot]]; | |||
'''ILD:''' [[Interstitial lung disease]]; | |||
'''ARDS:''' [[Acute respiratory distress syndrome]]; | |||
</span> | |||
<br> | |||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | C01 | | | | | | | | | | | | | | |C01= Mechanism of [[hypoxemia]] | }} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | C01 | | | | | | | | | | | | | | |C01= Mechanism of [[hypoxemia]] | }} | ||
Line 240: | Line 268: | ||
</div>}}{{family tree/end}} | </div>}}{{family tree/end}} | ||
<span style="font-size:85%">PAO2 is the mean alveolar oxygen pressure.</span> | |||
<span style="font-size:85%">PH2O is the water vapor pressure (47 mmHg at 37°C).</span> | |||
<span style="font-size:85%">PaCO2 is the alveolar carbon dioxide tension and is equal to arterial PCO2.</span> | |||
<span style="font-size:85%">R is the respiratory quotient and is 0.8 on the standard diet.</span> | |||
<span style="font-size:85%">FiO2 is the fractional concentration of inspired oxygen. It is 0.21 at room air.</span> | |||
P<span style="font-size:85%">AO2 = FiO2× (Pb − PH2O) − (PACO2/R)=0.21× (760 − 47) − (40/0.8)=100 mmHg.</span> | |||
Line 253: | Line 279: | ||
===Differential Diagnosis of Peripheral and Central Cyanosis=== | |||
<br> | |||
<br> | |||
{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{familytree | | | | | | | | | |,|-| A01 |-| A02 | | | |A01= [[Eisenmenger disease]] |A02=[[Increased pulmonary vascular resistant]] leading to right to left [[shunt]], systemic [[arterial desaturation]], [[central cyanosis]] }} | {{familytree | | | | | | | | | |,|-| A01 |-| A02 | | | |A01= [[Eisenmenger disease]] |A02=[[Increased pulmonary vascular resistant]] leading to right to left [[shunt]], systemic [[arterial desaturation]], [[central cyanosis]] }} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | |)|-| B01 |-| B02 | | | |B01=[[Tamponad]] |B02=low [[cardiac output]], [[low stroke volume]], [[elevated cardiac filling pressures]], increased [[sympathetic tone]]( [[tachycardia]], [[peripheral vasoconstriction]], peripheral cyanosis)}} | {{familytree | | | | | | | | | |)|-| B01 |-| B02 | | | |B01=[[Tamponad]] |B02=low [[cardiac output]], [[low stroke volume]], [[elevated cardiac filling pressures]], increased [[sympathetic tone]]( [[tachycardia]], [[peripheral vasoconstriction]], [[peripheral cyanosis]])<ref name="KearnsWalley2018">{{cite journal|last1=Kearns|first1=Mark J.|last2=Walley|first2=Keith R.|title=Tamponade|journal=Chest|volume=153|issue=5|year=2018|pages=1266–1275|issn=00123692|doi=10.1016/j.chest.2017.11.003}}</ref> | ||
}} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | |)|-| D01 |-| D02 | | | |D01=[[Pulmonary thromboembolism]] |D02= [[Pulmonary artery vasoconstriction]], [[hypoxia]], [[right ventricle]] pressure overload, right to left shunt via [[patent foramen ovale]],[[central cyanosis]] }} | {{familytree | | | | | | | | | |)|-| D01 |-| D02 | | | |D01=[[Pulmonary thromboembolism]] |D02= [[Pulmonary artery vasoconstriction]], [[hypoxia]], [[right ventricle]] pressure overload, right to left shunt via [[patent foramen ovale]],[[central cyanosis]]<ref name="MorroneMorrone2018">{{cite journal|last1=Morrone|first1=Doralisa|last2=Morrone|first2=Vincenzo|title=Acute Pulmonary Embolism: Focus on the Clinical Picture|journal=Korean Circulation Journal|volume=48|issue=5|year=2018|pages=365|issn=1738-5520|doi=10.4070/kcj.2017.0314}}</ref>}} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | |)|-| R1 |-| R2 | | | | | | | | |R1=[[ Cardiogenic shock]] |R2= Decreased [[myocardial perfusion]], muscle [[hypoxia]],necrosis, impaired [[myocardial contraction]]., decreased [[cardiac out put]], Increased vasoconstrictor,[[ peripheral cyanosis]] | }} | {{familytree | | | | | | | | | |)|-| R1 |-| R2 | | | | | | | | |R1=[[Cardiogenic shock]] |R2= Decreased [[myocardial perfusion]], muscle [[hypoxia]],necrosis, impaired [[myocardial contraction]]., decreased [[cardiac out put]], Increased vasoconstrictor,[[ peripheral cyanosis]]<ref name="pmid19924275">{{cite journal |vauthors=Khalid L, Dhakam SH |title=A review of cardiogenic shock in acute myocardial infarction |journal=Curr Cardiol Rev |volume=4 |issue=1 |pages=34–40 |date=February 2008 |pmid=19924275 |pmc=2774583 |doi=10.2174/157340308783565456 |url=}}</ref>}} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | |)|-| G01 |-| G02 | | | | |G01=[[Tetralogy of fallot]]| G02= Episods of Tet spell between 2-4 months of age, aggravated with crying ,feeding stooling,dehydration,in patients with severe [[pulmonary stenosis]] and large [[VSD]], [[central cyanosis]| }} | {{familytree | | | | | | | | | |)|-| G01 |-| G02 | | | | | | | | |G01=[[Tetralogy of fallot]]|G02= Episods of Tet spell between 2-4 months of age, aggravated with crying ,feeding stooling,dehydration,in patients with severe [[pulmonary stenosis]] and large [[VSD]], [[central cyanosis]]<ref name="O’BrienMarshall2014">{{cite journal|last1=O’Brien|first1=Patricia|last2=Marshall|first2=Audrey C.|title=Tetralogy of Fallot|journal=Circulation|volume=130|issue=4|year=2014|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.113.005547}}</ref> | ||
}} | |||
{{familytree | | | | | C01 |-|-|(| | | | | |C01= Differential diagnosis of peripheral and [[central cyanosis]]}} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | |)|-| H01 |-| H02 | | | | | | | | | H01=[[ Methemoglubinemia ]]|H02= Increased level of reduced [[hemoglobin | {{familytree | | | | | | | | | |)|-| H01 |-| H02 | | | | | | | | | H01=[[Methemoglubinemia]]|H02= Increased level of reduced [[hemoglobin]], [[congenital]] or due to [[medication]], [[central cyanosis]]<ref name="DekkerEppink2001">{{cite journal|last1=Dekker|first1=Jan|last2=Eppink|first2=Michel H. M.|last3=van Zwieten|first3=Rob|last4=de Rijk|first4=Thea|last5=Remacha|first5=Angel F.|last6=Law|first6=Lap Kay|last7=Li|first7=Albert M.|last8=Cheung|first8=Kam Lau|last9=van Berkel|first9=Willem J. H.|last10=Roos|first10=Dirk|title=Seven new mutations in the nicotinamide adenine dinucleotide reduced–cytochrome b5 reductase gene leading to methemoglobinemia type I|journal=Blood|volume=97|issue=4|year=2001|pages=1106–1114|issn=1528-0020|doi=10.1182/blood.V97.4.1106}}</ref>}} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | |)|-| I01 |-| I02 | | | | | | | | |I01=[[Chronic obstructive pulmonary disease]] |I02= [[Central cyanosis]], [[respiratory failure]], PO2<60 mmHg, PCO2>45mmHg while breathing at sea level, [[ | {{familytree | | | | | | | | | |)|-| I01 |-| I02 | | | | | | | | |I01=[[Chronic obstructive pulmonary disease]] |I02= [[Central cyanosis]], [[respiratory failure]], PO2<60 mmHg, PCO2>45mmHg while breathing at sea level, [[peripheral edema]] due to [[right heart failure]] |}} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | |)|-| J01 |-| J02 | | | | | | | | | | | | | | | | | | | | |J01= [[Pulmonary edema]]| J02= [[Decreased arterial oxygen saturation]], [[central cyanosis]] }} | {{familytree | | | | | | | | | |)|-| J01 |-| J02 | | | | | | | | | | | | | | | | | | | | |J01=[[Pulmonary edema]]| J02=[[Decreased arterial oxygen saturation]], [[central cyanosis]] }} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | |)|-| F01 |-| F02 | | | | | | | | |F01=[[High altitude]] |F02=[[Hypoxia]], peripheral [[cyanosis]] due to [[ischemia]] and [[occlusion]] small peripheral vessels, [[central cyanosis]] due to [[pulmonary edema]] in [[acute mountain sickness]], [[pulmonary hypertension]] in [[chronic mountain sickness]] |}} | {{familytree | | | | | | | | | |)|-| F01 |-| F02 | | | | | | | | |F01=[[High altitude]] |F02=[[Hypoxia]], peripheral [[cyanosis]] due to [[ischemia]] and [[occlusion]] small peripheral vessels, [[central cyanosis]] due to [[pulmonary edema]] in [[acute mountain sickness]], [[pulmonary hypertension]] in [[chronic mountain sickness]]<ref name="GuptaGupta2020">{{cite journal|last1=Gupta|first1=Amol|last2=Gupta|first2=Ravi|last3=Kumar|first3=Vinod|last4=Samarany|first4=Samir|title=Blue Toes at High Altitude: Peripheral Cyanosis|journal=The American Journal of Medicine|volume=133|issue=5|year=2020|pages=573–575|issn=00029343|doi=10.1016/j.amjmed.2019.08.057}}</ref>}} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | |)|-| L01 |-| L02 | | | | | | | | | L01= [[Pneumonia]] | L02=[[ Central cyanosis]] due to impaired gas exchange and [[intrapulmonary shunt]] }} | {{familytree | | | | | | | | | |)|-| L01 |-| L02 | | | | | | | | | L01= [[Pneumonia]] | L02=[[ Central cyanosis]] due to impaired gas exchange and [[intrapulmonary shunt]]}} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | |`|-| E01 |-| E02 | | | |E01=[[ ARDS]] |E02= Acute pulmonary parenchimal disease other than [[cardiac]] origin or [[volume overload]], [[alveolar]] filling with [[exudates]] or [[alveolar collapse]], [[central cyanosis]] due to decreased [[oxygen saturation]] and intrapulmonary shunting | {{familytree | | | | | | | | | |`|-| E01 |-| E02 | | | |E01=[[ARDS]] |E02= Acute pulmonary parenchimal disease other than [[cardiac]] origin or [[volume overload]], [[alveolar]] filling with [[exudates]] or [[alveolar collapse]], [[central cyanosis]] due to decreased [[oxygen saturation]] and intrapulmonary shunting<ref name="pmid30997228">{{cite journal |vauthors=Bourenne J, Carvelli J, Papazian L |title=Evolving definition of acute respiratory distress syndrome |journal=J Thorac Dis |volume=11 |issue=Suppl 3 |pages=S390–S393 |date=March 2019 |pmid=30997228 |pmc=6424760 |doi=10.21037/jtd.2018.12.24 |url=}}</ref>}} | ||
{{familytree/end}} | {{familytree/end}} | ||
<br> | |||
<br> | |||
<br> | |||
===Approach to Cyanosis at Birth=== | |||
<br> | |||
<br> | |||
{{familytree/start |summary=Sample 10}}{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=Sample 10}}{{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{familytree | | | | | B01 | | | | | B01=<div style="float: left; text-align: left; height: 30em; width: 17em; padding:1em;"> '''Differentiating [[cardiac]] and [[ | {{familytree | | | | | B01 | | | | | B01=<div style="float: left; text-align: left; height: 30em; width: 17em; padding:1em;"> '''Differentiating [[cardiac]] and [[pulmonary]] causes of cyanosis at birth:'''<br> | ||
---- | ---- | ||
❑ [[History]] and [[physical exam]] <br> ❑ [[Blood pressure]] measurement in four [[limbs]] <br> ❑ [[Oxygen saturation]] measurement <br> ❑ [[ECG]] <br> ❑ [[Chest-X-ray]] </div>}} | ❑ [[History]] and [[physical exam]] <br> ❑ [[Blood pressure]] measurement in four [[limbs]] <br> ❑ [[Oxygen saturation]] measurement <br> ❑ [[ECG]] <br> ❑ [[Chest-X-ray]] </div>}} | ||
Line 288: | Line 324: | ||
{{familytree | | | | | C01 | | | | | C01=<div style="float: left; text-align: left; height: 30em; width: 17em; padding:1em;"> '''Cardiac cause:'''<br> | {{familytree | | | | | C01 | | | | | C01=<div style="float: left; text-align: left; height: 30em; width: 17em; padding:1em;"> '''Cardiac cause:'''<br> | ||
---- | ---- | ||
❑ [[Cardiomegaly]] in [[CXR]] <br> ❑ Relatively comfortable at rest <br> ❑ Cyanosis may worsen with [[crying]]<br> ❑ Cardiac [[murmur]]<br> ❑ Abnormal [[rhythm]] or axis in [[ECG]]<br> ❑ Normal [[ | ❑ [[Cardiomegaly]] in [[CXR]] <br> ❑ Relatively comfortable at rest <br> ❑ Cyanosis may worsen with [[crying]]<br> ❑ Cardiac [[murmur]]<br> ❑ Abnormal [[rhythm]] or axis in [[ECG]]<br> ❑ Normal [[PCO2]] level<br> ❑ NO response to [[O2]] therapy <br> </div>}} | ||
{{familytree | | | | | |!| | | | | |}} | {{familytree | | | | | |!| | | | | |}} | ||
{{familytree | | | | | D01 | | | | |D01=<div style="float: left; text-align: left; height: 30em; width: 17em; padding:1em;"> '''Pulmonary cause:'''<br> | {{familytree | | | | | D01 | | | | |D01=<div style="float: left; text-align: left; height: 30em; width: 17em; padding:1em;"> '''Pulmonary cause:'''<br> | ||
---- | ---- | ||
❑ [[Respiratory distress]],[[ tachypnea]] at rest<br>❑ [[Rale]], [[crackle]], [[wheezing]] in [[chest]] [[auscultation]]<br>❑ Normal [[cardiac margine]] in [[CXR]]<br>❑ [[Ground glass]] appearance, [[pneumonia]], [[atelectasia]],[[ pneumothorax]] in [[CXR]]<br>❑ Normal [[ECG]] finding<br>❑ Elevated [[PCO2]] level<br>❑ Corrected with [[oxygen]] therapy<br></div>}}{{familytree/end}} | ❑ [[Respiratory distress]],[[ tachypnea]] at rest<br>❑ [[Rale]], [[crackle]], [[wheezing]] in [[chest]] [[auscultation]]<br>❑ Normal [[cardiac margine]] in [[CXR]]<br>❑ [[Ground glass]] appearance, [[pneumonia]], [[atelectasia]],[[ pneumothorax]] in [[CXR]]<br>❑ Normal [[ECG]] finding<br>❑ Elevated [[PCO2]] level<br>❑ Corrected with [[oxygen]] therapy<br></div>}}{{familytree/end}} | ||
{| style="cellpadding=0; cellspacing= 0; width: 600px;" | {| style="cellpadding=0; cellspacing= 0; width: 600px;" | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF;" align=center |''' Cyanosis in [[Congenital heart disease]]''' | | style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF;" align="center" |''' Cyanosis in [[Congenital heart disease]]''' | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | ''' Cyanosis + pulmonary edema at the time of birth:''' | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" |''' Cyanosis + pulmonary edema at the time of birth:''' | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | | style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align="left" | | ||
❑ [[TGA]] ([[Transposition of great vessel]]) without associated [[PDA]],[[VSD]],[[ ASD]] | ❑ [[TGA]] ([[Transposition of great vessel]]) without associated [[PDA]],[[VSD]],[[ ASD]]: two great arteries are misplaced, oxygenated pulmonary blood re-enter the pulmonary circulation via morphologic [[left ventricle]] and deoxygenated aorta blood re-enter the systemic circulation via morphologic [[right ventricle]] <br> | ||
❑ [[Total anomalous pulmonary venous connection]]([[TAPVR]]) | ❑ [[Total anomalous pulmonary venous connection]]([[TAPVR]]):connection between [[pulmonary veins]] and right system and mixing the oxygenated and deoxygenated blood <br> | ||
❑ [[Truncus arteriosus]] | ❑ [[Truncus arteriosus]]: one great vessel arise from both ventricle then the gives rise to the aorta and pulmonary artery<br> | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Cyanosis +[[shock]] and [[collapse]] within hours or days after birth:''' | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" |'''Cyanosis +[[shock]] and [[collapse]] within hours or days after birth:''' | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | | style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align="left" | | ||
❑ [[Tetralogy of fallot]]: [[pulmonary stenosis]] (valvular, subvalvular) with [[ventricular septum defect]] and overridding [[aorta]]<br> | ❑ [[Tetralogy of fallot]]: [[pulmonary stenosis]] (valvular, subvalvular) with [[ventricular septum defect]] and overridding [[aorta]]<ref name="O’BrienMarshall2014">{{cite journal|last1=O’Brien|first1=Patricia|last2=Marshall|first2=Audrey C.|title=Tetralogy of Fallot|journal=Circulation|volume=130|issue=4|year=2014|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.113.005547}}</ref> | ||
<br> | |||
❑ Severe [[ pulmonary stenosis]] with intact ventricular septum<br> | ❑ Severe [[ pulmonary stenosis]] with intact ventricular septum<br> | ||
❑ [[Ebstein anomaly]]: small functional [[right ventricle]], huge [[right atrium]], severe [[tricuspid regurgitation]], right to left shunt | ❑ [[Ebstein anomaly]]: small functional [[right ventricle]], huge [[right atrium]], severe [[tricuspid regurgitation]], right to left shunt via [[ASD]] or [[PFO]]<br> | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Cyanosis +[[shock]] and [[collapse]] in the first week of birth:''' | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" |'''Cyanosis +[[shock]] and [[collapse]] in the first week of birth:''' | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | | style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align="left" | | ||
❑ [[Hypoplastic left heart syndrome]]<br> | ❑ [[Hypoplastic left heart syndrome]]<br> | ||
❑ Severe [[coarctation of aorta]]<br> | ❑ Severe [[coarctation of aorta]]<br> | ||
Line 324: | Line 360: | ||
<span style="font-size:85%;color:red">[[Other differential diagnosis|<span style="color:red"> Other differential diagnosis:</span>]] [[neonate sepsis |<span style="color:red"> neonate sepsis,</span>]] [[ menangitis|<span style="color:red"> menangitis</span>]] or [[hypoglycemia|<span style="color:red">hypoglycemia</span>]] </span> | <span style="font-size:85%;color:red">[[Other differential diagnosis|<span style="color:red"> Other differential diagnosis:</span>]] [[neonate sepsis |<span style="color:red"> neonate sepsis,</span>]] [[ menangitis|<span style="color:red"> menangitis</span>]] or [[hypoglycemia|<span style="color:red">hypoglycemia</span>]] </span> | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |''' Differencial cyanosis ( upper limbs O2 saturation > lower limbs O2 saturation):''' | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" |''' Differencial cyanosis ( upper limbs O2 saturation > lower limbs O2 saturation):''' | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | | style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align="left" | | ||
❑ Severe [[pulmonary hypertension]] with [[PDA]]<ref name="SinghSingh2013">{{cite journal|last1=Singh|first1=Jaspreet|last2=Singh|first2=Akashdeep|title=Differential Cyanosis|journal=The American Journal of Medicine|volume=126|issue=10|year=2013|pages=e9|issn=00029343|doi=10.1016/j.amjmed.2013.03.014}}</ref> | ❑ Severe [[pulmonary hypertension]] with [[PDA]]<ref name="SinghSingh2013">{{cite journal|last1=Singh|first1=Jaspreet|last2=Singh|first2=Akashdeep|title=Differential Cyanosis|journal=The American Journal of Medicine|volume=126|issue=10|year=2013|pages=e9|issn=00029343|doi=10.1016/j.amjmed.2013.03.014}}</ref> | ||
<br> | <br> | ||
❑ Severe [[aortic coactation]] or interruption <br> | ❑ Severe [[aortic coactation]] or interruption <br> | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |''' Differencial cyanosis ( lower limbs O2 saturation> upper limbs O2 saturation):''' | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" |''' Differencial cyanosis ( lower limbs O2 saturation> upper limbs O2 saturation):''' | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | | style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align="left" | | ||
❑ [[TGA]] + severe [[pulmonary hypertension]] + [[PDA]]<ref name="pmid11265513">{{cite journal |vauthors=Marino BS, Bird GL, Wernovsky G |title=Diagnosis and management of the newborn with suspected congenital heart disease |journal=Clin Perinatol |volume=28 |issue=1 |pages=91–136 |date=March 2001 |pmid=11265513 |doi=10.1016/s0095-5108(05)70071-3 |url=}}</ref> <br> | ❑ [[TGA]] + severe [[pulmonary hypertension]] + [[PDA]]<ref name="pmid11265513">{{cite journal |vauthors=Marino BS, Bird GL, Wernovsky G |title=Diagnosis and management of the newborn with suspected congenital heart disease |journal=Clin Perinatol |volume=28 |issue=1 |pages=91–136 |date=March 2001 |pmid=11265513 |doi=10.1016/s0095-5108(05)70071-3 |url=}}</ref> <br> | ||
❑ [[TGA]] + severe [[aortic arch interruption]] + [[PDA]]<br> | ❑ [[TGA]] + severe [[aortic arch interruption]] + [[PDA]]<br> | ||
❑ Connection right [[subclavian artery]] to right [[pulmonary artery]] <span style="font-size:85%;color:red">[[Right upper limb saturation|<span style="color:red"> Right upper limb oxygen saturation</span>]] [[is lower |<span style="color:red"> is lower</span>]] [[ than|<span style="color:red"> than </span>]] [[ left upper and left lower limbs oxygen saturation|<span style="color:red"> left upper and left lower limbs oxygen saturation</span>]] </span> | ❑ Connection right [[subclavian artery]] to right [[pulmonary artery]] <span style="font-size:85%;color:red">[[Right upper limb saturation|<span style="color:red"> Right upper limb oxygen saturation</span>]] [[is lower |<span style="color:red"> is lower</span>]] [[ than|<span style="color:red"> than </span>]] [[ left upper and left lower limbs oxygen saturation|<span style="color:red"> left upper and left lower limbs oxygen saturation</span>]] </span> | ||
|} | |}<br /> | ||
==Treatment== | == Treatment == | ||
Shown below is an algorithm summarizing the treatment of | Shown below is an algorithm summarizing the treatment of cyanosis. | ||
{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{familytree | | | | | | | | | |,|-| A01 |-| A02 | | | |A01= [[TGA]], [[TAPVR ]],[[Truncus arteriosus]] |A02= Infusion of [[Prostaglandin]], [[Diuretic]] therapy,surgery <ref name="Rao2013">{{cite journal|last1=Rao|first1=P. Syamasundar|title=Consensus on Timing of Intervention for Common Congenital Heart Diseases: Part II - Cyanotic Heart Defects|journal=The Indian Journal of Pediatrics|volume=80|issue=8|year=2013|pages=663–674|issn=0019-5456|doi=10.1007/s12098-013-1039-2}}</ref> | {{familytree | | | | | | | | | |,|-| A01 |-| A02 | | | |A01= [[TGA]], [[TAPVR ]],[[Truncus arteriosus]] |A02= Infusion of [[Prostaglandin]], [[Diuretic]] therapy,surgery <ref name="Rao2013">{{cite journal|last1=Rao|first1=P. Syamasundar|title=Consensus on Timing of Intervention for Common Congenital Heart Diseases: Part II - Cyanotic Heart Defects|journal=The Indian Journal of Pediatrics|volume=80|issue=8|year=2013|pages=663–674|issn=0019-5456|doi=10.1007/s12098-013-1039-2}}</ref> | ||
}} | }} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | |)|-| B01 |-| B02 | | | |B01= [[TOF]]|B02= Hydration, modified [[ blalock taussing shunt]], insertion stent in [[PDA]] and [[right ventricular outflow tract]], total repair }} | {{familytree | | | | | | | | | |)|-| B01 |-| B02 | | | |B01= [[TOF]]|B02= Hydration, modified [[ blalock taussing shunt]], insertion stent in [[PDA]] and [[right ventricular outflow tract]], total repair <ref name="O’BrienMarshall2014">{{cite journal|last1=O’Brien|first1=Patricia|last2=Marshall|first2=Audrey C.|title=Tetralogy of Fallot|journal=Circulation|volume=130|issue=4|year=2014|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.113.005547}}</ref> | ||
}} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | {{familytree | | | | | | | | | |)|-| C02 |-| C03 | | | |C02= Ebstein anomaly |C03= [[Tricuspid valve]] repair<ref name="pmid31384377">{{cite journal |vauthors=Holst KA, Connolly HM, Dearani JA |title=Ebstein's Anomaly |journal=Methodist Debakey Cardiovasc J |volume=15 |issue=2 |pages=138–144 |date=2019 |pmid=31384377 |pmc=6668741 |doi=10.14797/mdcj-15-2-138 |url=}}</ref> }} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | {{familytree | | | | | | D00 |-|+|-| D01 |-| D02 | | | |D00=Treatment of Cyanosis | D01= [[Hypoplastic left heart syndrome]] |D02= Infusion of [[Prostaglandin]] for keeping patency of [[ductus arteriosus]], infusion of vasodilator for reduced systemic resistance, [[mechanical ventilation]] in shock state and imposing [[hypercapnia]] and [[alveolar hypoxia]] for increased [[pulmonary resistance]] }} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | |)|-| D01 |-| D02 | | | |D01= [[Sepsis]], [[shock]], low [[cardiac output]] state, [[cold exposure]], [[metabolic disorder]], [[polycythemia]]|D02= Treatment of underlying disorder}} | {{familytree | | | | | | | | | |)|-| D01 |-| D02 | | | |D01= [[Sepsis]], [[shock]], low [[cardiac output]] state, [[cold exposure]], [[metabolic disorder]], [[polycythemia]]|D02= Treatment of underlying disorder}} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | |)|-| D01 |-| D02 | | | |D01= [[Eisenmenger syndrome]] with [[pulmonary hypertension]],|D02= [[Phosphodiesterase-5 inhibitor ]] ([[sildenafil]], [[tadalafil]], [[Endothelin receptor antagonist]] ([[ bosentan]],[[ macitentan]], [[ambrisentan]])}} | {{familytree | | | | | | | | | |)|-| D01 |-| D02 | | | |D01= [[Eisenmenger syndrome]] with [[pulmonary hypertension]],|D02= [[Phosphodiesterase-5 inhibitor ]] ([[sildenafil]], [[tadalafil]]), [[Endothelin receptor antagonist]] ([[ bosentan]],[[ macitentan]], [[ambrisentan]])<ref name="pmid28536680">{{cite journal |vauthors=de Campos FPF, Benvenuti LA |title=Eisenmenger syndrome |journal=Autops Case Rep |volume=7 |issue=1 |pages=5–7 |date=2017 |pmid=28536680 |pmc=5436914 |doi=10.4322/acr.2017.006 |url=}}</ref>}} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
Line 361: | Line 398: | ||
==Do's== | ==Do's== | ||
* Quickly think about [[hypoplastic left heart syndrome]] | |||
* In [[ebstein anomaly]] | *Quickly think about [[hypoplastic left heart syndrome]] in infants with sudden onset of [[shock]], [[collapse]] and severe [[anemia]] in the first week of life, as well as neonate [[sepsis]] and [[metabolic disorders]].<ref name="pmid28356795">{{cite journal |vauthors=Gobergs R, Salputra E, Lubaua I |title=Hypoplastic left heart syndrome: a review |journal=Acta Med Litu |volume=23 |issue=2 |pages=86–98 |date=2016 |pmid=28356795 |pmc=5088741 |doi=10.6001/actamedica.v23i2.3325 |url=}}</ref> | ||
* In differential cyanosis if oxygen saturation of [[right arm]] is more than [[legs]] and improves with O2 supplemental therapy, | *In [[ebstein anomaly]], repair of [[tricuspid valve]] indicates if there is :[[Cyanosis]], [[Right-side heart failure]], Poor [[functional capacity]], [[Paradoxical emboli]]<ref name="pmid31384377">{{cite journal |vauthors=Holst KA, Connolly HM, Dearani JA |title=Ebstein's Anomaly |journal=Methodist Debakey Cardiovasc J |volume=15 |issue=2 |pages=138–144 |date=2019 |pmid=31384377 |pmc=6668741 |doi=10.14797/mdcj-15-2-138 |url=}}</ref>. | ||
* In the presence of [[central cyanosis]] + [[hemolytic anemia]] ([[jundic]],[[ heinze body]],[[fragment RBC]])+ [[renal failure]] consider | *In differential cyanosis if oxygen saturation of [[right arm]] is more than [[legs]] and improves with O2 supplemental therapy, consider severe [[coarctation of aorta]], [[aortic arch interruption]], [[primary pulmonary hypertension]]. | ||
* Quickly correct [[dehydration]] and any distress in infants with cyanotic tet spell in [[Tetralogy of Fallot]] to maintain [[pulmonary blood flow]] through atretic [[pulmonary artery]] and | *In the presence of [[central cyanosis]] + [[hemolytic anemia]] ([[jundic]],[[ heinze body]],[[fragment RBC]])+ [[renal failure]] consider [[methemoglobinemia]]. | ||
* | *Quickly correct [[dehydration]] and any distress in infants with cyanotic tet spell in [[Tetralogy of Fallot]] to maintain [[pulmonary blood flow]] through atretic [[pulmonary artery]] and reduce right to left shunt through [[VSD]].<ref name="O’BrienMarshall2014">{{cite journal|last1=O’Brien|first1=Patricia|last2=Marshall|first2=Audrey C.|title=Tetralogy of Fallot|journal=Circulation|volume=130|issue=4|year=2014|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.113.005547}}</ref> | ||
*Consider [[paradoxical embolism]] and perform a [[Brain CT scan]] in the presence of new neurologic symptoms in [[cyanotic]] [[congenital heart disease]] because of passing the [[emboli]] from right to left shunt and [[hyperviscosity]] leading to [[thrombosis]].<ref>{{cite journal|doi=10.1161/STROKEAHA.116.012882Stroke}}</ref> | |||
==Don'ts== | ==Don'ts== | ||
*Cyanotic congenital heart diseases that [[pulmonary congestion]] is independent on [[patent ductus arteriosus]]([[PDA]]) and which do not worsen with [[dehydration]] include : | |||
*[[Transposition of great arteries]]([[TGA]]) | *[[Transposition of great arteries]]([[TGA]]) | ||
*[[Truncus arteriosus]]([[TA]]) | *[[Truncus arteriosus]]([[TA]]) | ||
*[[Total anomalous pulmonary venous connection]]([[TAPVR]]) | *[[Total anomalous pulmonary venous connection]]([[TAPVR]])<ref name="pmid25580197">{{cite journal |vauthors=Kim HS, Jeong K, Cho HJ, Choi WY, Choi YE, Ma JS, Cho YK |title=Total anomalous pulmonary venous return in siblings |journal=J Cardiovasc Ultrasound |volume=22 |issue=4 |pages=213–9 |date=December 2014 |pmid=25580197 |pmc=4286644 |doi=10.4250/jcu.2014.22.4.213 |url=}}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Resident survival guide]] | [[Category:Resident survival guide]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
Latest revision as of 10:07, 12 February 2021
Cyanosis Resident Survival Guide Microchapters |
---|
Overview |
Causes |
Diagnosis |
Differential Diagnosis |
Treatment |
Do's |
Don'ts |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Chandrakala Yannam, MD [3]
Synonyms and keywords: Cyanosis approach, Cyanosis workup, Cyanosis management, Approach to blue discoloration of skin, Hypoxemia approach, Hypoxia approach
Overview
Cyanosis is defined as bluish discoloration of skin and mucous membrane due to decreased oxygenation of tissue. Approximately 2% of oxygen dissolved in plasma and 98% is carried by hemoglobin. In central cyanosis, there is decreased oxygen saturation (less than 85%) or abnormal or nonfunctional hemoglobin, depending on whether reduced hemoglobin or desaturated hemoglobin exceeds 5 g/dl. Common signs of central cyanosis include the tongue and conjunctiva appearing blue in color and the extremities becoming warm with rapid capillary filling. In peripheral cyanosis, the oxygen saturation is normal but there is inadequate delivery of oxygen to tissue or increased oxygen extraction by tissue due to peripheral vasoconstriction. In peripheral cyanosis extremities are cyanotic, pale, cool but tongue and conjunctiva are pinkish. All causes of central cyanosis may lead to peripheral cyanosis. In the presence of anemia and severe hypoxemia, cyanosis may not be apparent due to fewer levels of reduced hemoglobin. Conversely, in polycythemia and mild hypoxemia, cyanosis may be easily apparent due to an increased level of reduced hemoglobin.
Causes
Life Threatening Causes
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
- Carbon monoxide poisoning [1]
- Cyanide poisoning [2]
- Malathion
- Parathion
- Ethylene glycol
- Epiglottitis
- Foreign body aspiration [3]
- Pulmonary embolism[4]
- Tension pneumothorax [5]
- Hemothorax
- Pulmonary hemorrhage
- Pulmonary hypertension [6]
- Myocardial infarction
- Congestive heart failure
- Disseminated intravascular coagulation[7]
- Tetralogy of fallout [8]
- Cardiac tamponade [9]
- Eisenmenger syndrome [10]
- Anaphylaxis
- Birth asphyxia [11]
- Amniotic fluid embolism[12]
Common Causes
Cyanosis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Central cyanosis | Peripheral cyanosis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hematologic abnormalities: [13] ❑ Methemoglobinemia (congenital or acquired)
❑ Polycythemia vera
❑ Venomous snakebites [16]
❑ Brief resolved unexplained events (BRUE) [17] | Hypoventilation:: Upper airway obstruction: [19][3] ❑ Foreign body aspiration
Neurologic abnormalities: [21][22][23] | Vascular causes: ❑ Cardiac tamponade
❑ Eisenmenger syndrome | Conditions associated with decreased concentration of inspired oxygen (FiO2): [32] ❑ Smoke inhalation most commonly from house fires | Causes: [34][35] ❑ Cold exposure ❑ Venous obstruction: ❑ Decreased cardiac output: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pseudocyanosis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Metals | Extensive tattoos | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Drugs | Pigmentary lesions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consumption of dyed food | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnosis
Abbreviations:
TGA: Transposition of great arteries;
COPD: Chronic obstructive pulmonary disease;
PDA: Patent ductus arteriosus ;
ASD: Atrial septal defect;
VSD: Ventricular septal defect;
TAPVR: Total anomalous pulmonary venous return;
TOF: Tetralogy of fallot;
ILD: Interstitial lung disease;
ARDS: Acute respiratory distress syndrome;
Mechanism of hypoxemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
V/Q mismatch: ❑ Common cause of hypoxemia[36]
Diffusion limitation: | Right to left shunt: ❑ Poor response to oxygen therapy | Hypoventilation: ❑ High PCO2 level
❑ Spinal cord level: ❑nerve supplying respiratory muscle: ❑ Neuromascular junction: ❑Respiratory muscle: ❑ Defect in chest wall: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PAO2 is the mean alveolar oxygen pressure. PH2O is the water vapor pressure (47 mmHg at 37°C). PaCO2 is the alveolar carbon dioxide tension and is equal to arterial PCO2. R is the respiratory quotient and is 0.8 on the standard diet. FiO2 is the fractional concentration of inspired oxygen. It is 0.21 at room air. PAO2 = FiO2× (Pb − PH2O) − (PACO2/R)=0.21× (760 − 47) − (40/0.8)=100 mmHg.
Differential Diagnosis of Peripheral and Central Cyanosis
Approach to Cyanosis at Birth
Differentiating cardiac and pulmonary causes of cyanosis at birth: ❑ History and physical exam ❑ Blood pressure measurement in four limbs ❑ Oxygen saturation measurement ❑ ECG ❑ Chest-X-ray | |||||||||||||||||||||||
Pulmonary cause: ❑ Respiratory distress,tachypnea at rest ❑ Rale, crackle, wheezing in chest auscultation ❑ Normal cardiac margine in CXR ❑ Ground glass appearance, pneumonia, atelectasia,pneumothorax in CXR ❑ Normal ECG finding ❑ Elevated PCO2 level ❑ Corrected with oxygen therapy | |||||||||||||||||||||||
Cyanosis in Congenital heart disease |
Cyanosis + pulmonary edema at the time of birth: |
❑ TGA (Transposition of great vessel) without associated PDA,VSD,ASD: two great arteries are misplaced, oxygenated pulmonary blood re-enter the pulmonary circulation via morphologic left ventricle and deoxygenated aorta blood re-enter the systemic circulation via morphologic right ventricle |
Cyanosis +shock and collapse within hours or days after birth: |
❑ Tetralogy of fallot: pulmonary stenosis (valvular, subvalvular) with ventricular septum defect and overridding aorta[43]
|
Cyanosis +shock and collapse in the first week of birth: |
❑ Hypoplastic left heart syndrome |
Differencial cyanosis ( upper limbs O2 saturation > lower limbs O2 saturation): |
❑ Severe pulmonary hypertension with PDA[47]
|
Differencial cyanosis ( lower limbs O2 saturation> upper limbs O2 saturation): |
❑ TGA + severe pulmonary hypertension + PDA[48] |
Treatment
Shown below is an algorithm summarizing the treatment of cyanosis.
TGA, TAPVR ,Truncus arteriosus | Infusion of Prostaglandin, Diuretic therapy,surgery [49] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
TOF | Hydration, modified blalock taussing shunt, insertion stent in PDA and right ventricular outflow tract, total repair [43] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ebstein anomaly | Tricuspid valve repair[50] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment of Cyanosis | Hypoplastic left heart syndrome | Infusion of Prostaglandin for keeping patency of ductus arteriosus, infusion of vasodilator for reduced systemic resistance, mechanical ventilation in shock state and imposing hypercapnia and alveolar hypoxia for increased pulmonary resistance | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Sepsis, shock, low cardiac output state, cold exposure, metabolic disorder, polycythemia | Treatment of underlying disorder | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Eisenmenger syndrome with pulmonary hypertension, | Phosphodiesterase-5 inhibitor (sildenafil, tadalafil), Endothelin receptor antagonist (bosentan,macitentan, ambrisentan)[51] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Methemoglobinemia | Infusion of Methylenblue,dextrose,N-acetyl cystein,cimethidin,ketoconazole | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- Quickly think about hypoplastic left heart syndrome in infants with sudden onset of shock, collapse and severe anemia in the first week of life, as well as neonate sepsis and metabolic disorders.[52]
- In ebstein anomaly, repair of tricuspid valve indicates if there is :Cyanosis, Right-side heart failure, Poor functional capacity, Paradoxical emboli[50].
- In differential cyanosis if oxygen saturation of right arm is more than legs and improves with O2 supplemental therapy, consider severe coarctation of aorta, aortic arch interruption, primary pulmonary hypertension.
- In the presence of central cyanosis + hemolytic anemia (jundic,heinze body,fragment RBC)+ renal failure consider methemoglobinemia.
- Quickly correct dehydration and any distress in infants with cyanotic tet spell in Tetralogy of Fallot to maintain pulmonary blood flow through atretic pulmonary artery and reduce right to left shunt through VSD.[43]
- Consider paradoxical embolism and perform a Brain CT scan in the presence of new neurologic symptoms in cyanotic congenital heart disease because of passing the emboli from right to left shunt and hyperviscosity leading to thrombosis.[53]
Don'ts
- Cyanotic congenital heart diseases that pulmonary congestion is independent on patent ductus arteriosus(PDA) and which do not worsen with dehydration include :
- Transposition of great arteries(TGA)
- Truncus arteriosus(TA)
- Total anomalous pulmonary venous connection(TAPVR)[54]
References
- ↑ Olson K, Smollin C (July 2008). "Carbon monoxide poisoning (acute)". BMJ Clin Evid. 2008. PMC 2907971. PMID 19445736.
- ↑ Parker-Cote JL, Rizer J, Vakkalanka JP, Rege SV, Holstege CP (February 2018). "Challenges in the diagnosis of acute cyanide poisoning". Clin Toxicol (Phila): 1–9. doi:10.1080/15563650.2018.1435886. PMID 29417853.
- ↑ 3.0 3.1 Zoorob RJ, Campbell JS (November 2003). "Acute dyspnea in the office". Am Fam Physician. 68 (9): 1803–10. PMID 14620600.
- ↑ Just-Viera JO, Norwood T, Yeager GH (April 1967). "Importance of shock and cyanosis in pulmonary embolism". Ann. Surg. 165 (4): 528–35. PMC 1617449. PMID 6021453.
- ↑ Barton ED (July 1999). "Tension pneumothorax". Curr Opin Pulm Med. 5 (4): 269–74. PMID 10407699.
- ↑ Wang RF, Hung TY, Chong CF, Wang TL, Chen CC (February 2008). "Central cyanosis due to severe pulmonary hypertension combined with pericarditis as the initial manifestation of systemic lupus erythematosus". Am J Emerg Med. 26 (2): 248.e1–2. doi:10.1016/j.ajem.2007.04.007. PMID 18272123.
- ↑ Costello RA, Nehring SM. PMID 28722864. Missing or empty
|title=
(help) - ↑ 8.0 8.1 8.2 Bailliard F, Anderson RH (January 2009). "Tetralogy of Fallot". Orphanet J Rare Dis. 4: 2. doi:10.1186/1750-1172-4-2. PMC 2651859. PMID 19144126.
- ↑ Bodson L, Bouferrache K, Vieillard-Baron A (October 2011). "Cardiac tamponade". Curr Opin Crit Care. 17 (5): 416–24. doi:10.1097/MCC.0b013e3283491f27. PMID 21716107.
- ↑ Komine S (February 1964). "In vitro studies on the degradation and synthesis of serum proteins in placentae. I. Synthesis of serum proteins". Nippon Juigaku Zasshi. 26 (1): 15–23. PMID 4173631.
- ↑ Steinhorn RH (September 2008). "Evaluation and management of the cyanotic neonate". Clin Pediatr Emerg Med. 9 (3): 169–175. doi:10.1016/j.cpem.2008.06.006. PMC 2598396. PMID 19727322.
- ↑ 12.0 12.1 Kaur K, Bhardwaj M, Kumar P, Singhal S, Singh T, Hooda S (2016). "Amniotic fluid embolism". J Anaesthesiol Clin Pharmacol. 32 (2): 153–9. doi:10.4103/0970-9185.173356. PMC 4874066. PMID 27275041.
- ↑ Martínez de Zabarte Fernández JM, García Íñiguez JP, Domínguez Cajal M (February 2018). "Metahemoglobinemia in infants over one year". Med Clin (Barc). doi:10.1016/j.medcli.2017.12.009. PMID 29439874.
- ↑ Günal E, Akkuş Y, Çığşar G, Çiftçi H, Kahramanca Ş, Özdemir M (October 2017). "Methemoglobinemia incidence after the application of lidocaine for small surgical procedures". Agri. 29 (4): 173–176. PMID 29171648.
- ↑ Hilbert P, Zur Nieden K (September 2004). "[Suicidal fatal beta-blocker intoxication]". Anaesthesist (in German). 53 (9): 826–9. doi:10.1007/s00101-004-0721-1. PMID 15249969.
- ↑ Hifumi T, Sakai A, Kondo Y, Yamamoto A, Morine N, Ato M, Shibayama K, Umezawa K, Kiriu N, Kato H, Koido Y, Inoue J, Kawakita K, Kuroda Y (2015). "Venomous snake bites: clinical diagnosis and treatment". J Intensive Care. 3 (1): 16. doi:10.1186/s40560-015-0081-8. PMC 4393627. PMID 25866646.
- ↑ Kondamudi NP, Virji M. PMID 28722926. Missing or empty
|title=
(help) - ↑ Jensen JD, Vincent AL. PMID 28613569. Missing or empty
|title=
(help) - ↑ Gossman WG, Burns B. PMID 29261942. Missing or empty
|title=
(help) - ↑ Jain S, Bakshi N, Krishnamurti L (December 2017). "Acute Chest Syndrome in Children with Sickle Cell Disease". Pediatr Allergy Immunol Pulmonol. 30 (4): 191–201. doi:10.1089/ped.2017.0814. PMC 5733742. PMID 29279787.
- ↑ Kondamudi NP, Dulebohn SC. PMID 28722923. Missing or empty
|title=
(help) - ↑ Kondamudi NP, Wilt AS. PMID 28722998. Missing or empty
|title=
(help) - ↑ Memon J, Manganaro SN. PMID 28722938. Missing or empty
|title=
(help) - ↑ Bergeron M, Cohen AP, Cotton RT (2017). "The Management of Cyanotic Spells in Children with Oesophageal Atresia". Front Pediatr. 5: 106. doi:10.3389/fped.2017.00106. PMC 5430373. PMID 28555179.
- ↑ Maitre B, Similowski T, Derenne JP (September 1995). "Physical examination of the adult patient with respiratory diseases: inspection and palpation". Eur. Respir. J. 8 (9): 1584–93. PMID 8575588.
- ↑ Hermansen CL, Mahajan A (December 2015). "Newborn Respiratory Distress". Am Fam Physician. 92 (11): 994–1002. PMID 26760414.
- ↑ Bishop NB, Stankiewicz P, Steinhorn RH (July 2011). "Alveolar capillary dysplasia". Am. J. Respir. Crit. Care Med. 184 (2): 172–9. doi:10.1164/rccm.201010-1697CI. PMC 3172887. PMID 21471096.
- ↑ Justice NA, Le JK. PMID 28722988. Missing or empty
|title=
(help) - ↑ Reuter S, Moser C, Baack M (October 2014). "Respiratory distress in the newborn". Pediatr Rev. 35 (10): 417–28, quiz 429. doi:10.1542/pir.35-10-417. PMC 4533247. PMID 25274969.
- ↑ Woods WA, McCulloch MA (November 2005). "Cardiovascular emergencies in the pediatric patient". Emerg. Med. Clin. North Am. 23 (4): 1233–49. doi:10.1016/j.emc.2005.07.003. PMID 16199347.
- ↑ Driscoll DJ (February 1990). "Evaluation of the cyanotic newborn". Pediatr. Clin. North Am. 37 (1): 1–23. PMID 2407997.
- ↑ Dueñas-Laita A, Burillo Putze G, Alonso JR, Bajo A, Climent B, Corral E, Felices F, Ferrer A, Hernández Frutos MP, Nogué S, Puiguriguer J (December 2010). "[Basis for the clinical management of fire smoke poisoning "Docohumo Madrid 2010"]". Med Intensiva (in Spanish; Castilian). 34 (9): 609–19. doi:10.1016/j.medin.2010.07.007. PMID 21051109.
- ↑ Costumbrado J, Ghassemzadeh S. PMID 29083723. Missing or empty
|title=
(help) - ↑ Fardoun MM, Nassif J, Issa K, Baydoun E, Eid AH (2016). "Raynaud's Phenomenon: A Brief Review of the Underlying Mechanisms". Front Pharmacol. 7: 438. doi:10.3389/fphar.2016.00438. PMC 5110514. PMID 27899893.
- ↑ Das S, Maiti A (November 2013). "Acrocyanosis: an overview". Indian J Dermatol. 58 (6): 417–20. doi:10.4103/0019-5154.119946. PMC 3827510. PMID 24249890.
- ↑ Belda, F.J.; Soro, M.; Ferrando, C. (2013). "Pathophysiology of respiratory failure". Trends in Anaesthesia and Critical Care. 3 (5): 265–269. doi:10.1016/j.tacc.2013.05.003. ISSN 2210-8440.
- ↑ 37.0 37.1 Petersson J, Glenny RW (October 2014). "Gas exchange and ventilation-perfusion relationships in the lung". Eur. Respir. J. 44 (4): 1023–41. doi:10.1183/09031936.00037014. PMID 25063240.
- ↑ Gunning, Kevin EJ (2003). "Pathophysiology of Respiratory Failure and Indications for Respiratory Support". Surgery (Oxford). 21 (3): 72–76. doi:10.1383/surg.21.3.72.14672. ISSN 0263-9319.
- ↑ AVIADO DM, DALY MD, LEE CY, SCHMIDT CF (March 1961). "The contribution of the bronchial circulation to the venous admixture in pulmonary venous blood". J. Physiol. (Lond.). 155: 602–22. doi:10.1113/jphysiol.1961.sp006650. PMC 1359878. PMID 13685279.
- ↑ Kearns, Mark J.; Walley, Keith R. (2018). "Tamponade". Chest. 153 (5): 1266–1275. doi:10.1016/j.chest.2017.11.003. ISSN 0012-3692.
- ↑ Morrone, Doralisa; Morrone, Vincenzo (2018). "Acute Pulmonary Embolism: Focus on the Clinical Picture". Korean Circulation Journal. 48 (5): 365. doi:10.4070/kcj.2017.0314. ISSN 1738-5520.
- ↑ Khalid L, Dhakam SH (February 2008). "A review of cardiogenic shock in acute myocardial infarction". Curr Cardiol Rev. 4 (1): 34–40. doi:10.2174/157340308783565456. PMC 2774583. PMID 19924275.
- ↑ 43.0 43.1 43.2 43.3 O’Brien, Patricia; Marshall, Audrey C. (2014). "Tetralogy of Fallot". Circulation. 130 (4). doi:10.1161/CIRCULATIONAHA.113.005547. ISSN 0009-7322.
- ↑ Dekker, Jan; Eppink, Michel H. M.; van Zwieten, Rob; de Rijk, Thea; Remacha, Angel F.; Law, Lap Kay; Li, Albert M.; Cheung, Kam Lau; van Berkel, Willem J. H.; Roos, Dirk (2001). "Seven new mutations in the nicotinamide adenine dinucleotide reduced–cytochrome b5 reductase gene leading to methemoglobinemia type I". Blood. 97 (4): 1106–1114. doi:10.1182/blood.V97.4.1106. ISSN 1528-0020.
- ↑ Gupta, Amol; Gupta, Ravi; Kumar, Vinod; Samarany, Samir (2020). "Blue Toes at High Altitude: Peripheral Cyanosis". The American Journal of Medicine. 133 (5): 573–575. doi:10.1016/j.amjmed.2019.08.057. ISSN 0002-9343.
- ↑ Bourenne J, Carvelli J, Papazian L (March 2019). "Evolving definition of acute respiratory distress syndrome". J Thorac Dis. 11 (Suppl 3): S390–S393. doi:10.21037/jtd.2018.12.24. PMC 6424760. PMID 30997228.
- ↑ Singh, Jaspreet; Singh, Akashdeep (2013). "Differential Cyanosis". The American Journal of Medicine. 126 (10): e9. doi:10.1016/j.amjmed.2013.03.014. ISSN 0002-9343.
- ↑ Marino BS, Bird GL, Wernovsky G (March 2001). "Diagnosis and management of the newborn with suspected congenital heart disease". Clin Perinatol. 28 (1): 91–136. doi:10.1016/s0095-5108(05)70071-3. PMID 11265513.
- ↑ Rao, P. Syamasundar (2013). "Consensus on Timing of Intervention for Common Congenital Heart Diseases: Part II - Cyanotic Heart Defects". The Indian Journal of Pediatrics. 80 (8): 663–674. doi:10.1007/s12098-013-1039-2. ISSN 0019-5456.
- ↑ 50.0 50.1 Holst KA, Connolly HM, Dearani JA (2019). "Ebstein's Anomaly". Methodist Debakey Cardiovasc J. 15 (2): 138–144. doi:10.14797/mdcj-15-2-138. PMC 6668741 Check
|pmc=
value (help). PMID 31384377. - ↑ de Campos F, Benvenuti LA (2017). "Eisenmenger syndrome". Autops Case Rep. 7 (1): 5–7. doi:10.4322/acr.2017.006. PMC 5436914. PMID 28536680. Vancouver style error: initials (help)
- ↑ Gobergs R, Salputra E, Lubaua I (2016). "Hypoplastic left heart syndrome: a review". Acta Med Litu. 23 (2): 86–98. doi:10.6001/actamedica.v23i2.3325. PMC 5088741. PMID 28356795.
- ↑ . doi:10.1161/STROKEAHA.116.012882Stroke. Missing or empty
|title=
(help) - ↑ Kim HS, Jeong K, Cho HJ, Choi WY, Choi YE, Ma JS, Cho YK (December 2014). "Total anomalous pulmonary venous return in siblings". J Cardiovasc Ultrasound. 22 (4): 213–9. doi:10.4250/jcu.2014.22.4.213. PMC 4286644. PMID 25580197.